194 related articles for article (PubMed ID: 35724267)
21. Autism and Epilepsy in Patients With Tuberous Sclerosis Complex.
Specchio N; Pietrafusa N; Trivisano M; Moavero R; De Palma L; Ferretti A; Vigevano F; Curatolo P
Front Neurol; 2020; 11():639. PubMed ID: 32849171
[No Abstract] [Full Text] [Related]
22. Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorder.
Prohl AK; Scherrer B; Tomas-Fernandez X; Davis PE; Filip-Dhima R; Prabhu SP; Peters JM; Bebin EM; Krueger DA; Northrup H; Wu JY; Sahin M; Warfield SK;
J Neurodev Disord; 2019 Dec; 11(1):36. PubMed ID: 31838998
[TBL] [Abstract][Full Text] [Related]
23. Perinatal adversities in tuberous sclerosis complex: Determinants and neurodevelopmental outcomes.
Zhang AXD; Liang H; McEwen FS; Tye C; Woodhouse E; Underwood L; Shephard E; Sheerin F; ; Bolton PF
Dev Med Child Neurol; 2022 Oct; 64(10):1237-1245. PubMed ID: 35366331
[TBL] [Abstract][Full Text] [Related]
24. Utility of the Autism Observation Scale for Infants in Early Identification of Autism in Tuberous Sclerosis Complex.
Capal JK; Horn PS; Murray DS; Byars AW; Bing NM; Kent B; Bucher LA; Williams ME; O'Kelley S; Pearson DA; Sahin M; Krueger DA;
Pediatr Neurol; 2017 Oct; 75():80-86. PubMed ID: 28844798
[TBL] [Abstract][Full Text] [Related]
25. Corpus Callosum White Matter Diffusivity Reflects Cumulative Neurological Comorbidity in Tuberous Sclerosis Complex.
Baumer FM; Peters JM; Clancy S; Prohl AK; Prabhu SP; Scherrer B; Jansen FE; Braun KPJ; Sahin M; Stamm A; Warfield SK
Cereb Cortex; 2018 Oct; 28(10):3665-3672. PubMed ID: 29939236
[TBL] [Abstract][Full Text] [Related]
26. Early predictors of clinical and mental outcome in tuberous sclerosis complex: A prospective study.
Benova B; Petrak B; Kyncl M; Jezdik P; Maulisova A; Jahodova A; Komarek V; Krsek P
Eur J Paediatr Neurol; 2018 Jul; 22(4):632-641. PubMed ID: 29636221
[TBL] [Abstract][Full Text] [Related]
27. Self-injury and aggression in adults with tuberous sclerosis complex: Frequency, associated person characteristics, and implications for assessment.
Wilde L; Eden K; de Vries P; Moss J; Welham A; Oliver C
Res Dev Disabil; 2017 May; 64():119-130. PubMed ID: 28411579
[TBL] [Abstract][Full Text] [Related]
28. Understanding speech and language in tuberous sclerosis complex.
Gipson TT; Oller DK; Messinger DS; Perry LK
Front Hum Neurosci; 2023; 17():1149071. PubMed ID: 37323931
[TBL] [Abstract][Full Text] [Related]
29. Autism in tuberous sclerosis complex.
Gutierrez GC; Smalley SL; Tanguay PE
J Autism Dev Disord; 1998 Apr; 28(2):97-103. PubMed ID: 9586771
[TBL] [Abstract][Full Text] [Related]
30. EEG Spectral Features in Sleep of Autism Spectrum Disorders in Children with Tuberous Sclerosis Complex.
Cook IA; Wilson AC; Peters JM; Goyal MN; Bebin EM; Northrup H; Krueger D; Leuchter AF; Sahin M;
J Autism Dev Disord; 2020 Mar; 50(3):916-923. PubMed ID: 31811616
[TBL] [Abstract][Full Text] [Related]
31. Aspects of autism spectrum disorder and correlation with neuroimaging findings in tuberous sclerosis complex.
Dedeoğlu Ö; Çetinkaya M; Emine Derinkuyu B; Aksoy E; Öztoprak Ü; Genç Sel Ç; Nursun Özcan H; Aksoy A; Yüksel D
Clin Neurol Neurosurg; 2023 Jan; 224():107550. PubMed ID: 36502649
[TBL] [Abstract][Full Text] [Related]
32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
33. Cortical dysplasia and autistic trait severity in children with Tuberous Sclerosis Complex: a clinical epidemiological study.
Mous SE; Overwater IE; Vidal Gato R; Duvekot J; Ten Hoopen LW; Lequin MH; de Wit MY; Dieleman GC
Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):753-765. PubMed ID: 29063203
[TBL] [Abstract][Full Text] [Related]
34. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
McClain MB; Hasty Mills AM; Murphy LE
Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
[TBL] [Abstract][Full Text] [Related]
35. Methylphenidate for children and adolescents with autism spectrum disorder.
Sturman N; Deckx L; van Driel ML
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
[TBL] [Abstract][Full Text] [Related]
36. Daily living skills in children with autism spectrum disorder and intellectual disability: A comparative study from Turkey.
Kilincaslan A; Kocas S; Bozkurt S; Kaya I; Derin S; Aydin R
Res Dev Disabil; 2019 Feb; 85():187-196. PubMed ID: 30576945
[TBL] [Abstract][Full Text] [Related]
37. Self-injury and aggression in tuberous sclerosis complex: cross syndrome comparison and associated risk markers.
Eden KE; de Vries PJ; Moss J; Richards C; Oliver C
J Neurodev Disord; 2014; 6(1):10. PubMed ID: 24822087
[TBL] [Abstract][Full Text] [Related]
38. The relationship of neuroimaging findings and neuropsychiatric comorbidities in children with tuberous sclerosis complex.
Huang CH; Peng SS; Weng WC; Su YN; Lee WT;
J Formos Med Assoc; 2015 Sep; 114(9):849-54. PubMed ID: 24698169
[TBL] [Abstract][Full Text] [Related]
39. Autism and tuberous sclerosis.
Smalley SL
J Autism Dev Disord; 1998 Oct; 28(5):407-14. PubMed ID: 9813776
[TBL] [Abstract][Full Text] [Related]
40. An Updated Review of Tuberous Sclerosis Complex-Associated Autism Spectrum Disorder.
Samanta D
Pediatr Neurol; 2020 Aug; 109():4-11. PubMed ID: 32563542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
